As pet obesity rates rise, so does the prevalence of diabetes in cats and dogs. One in 100 dogs and one in 200-250 cats has diabetes.1,2 With this many pets and pet owners affected, it should be no surprise that BD has made it a priority to design specific devices to make this disease manageable for veterinarians and pet owners. For example, our U-40 syringe is carefully designed to make insulin administration comfortable for pets, minimizing squirming and potential injuries during the injection process.
BD U-40 veterinary insulin syringes
Cost-effective for clinics so you can pass the savings along to clients with pet-specific packaging that helps drive pet owners back into the clinic for refill purchases.
- Manufactured in Holdrege, Nebraska, USA
- Only veterinary-specific insulin syringe in the USA with red-colored scale marks to indicate use for U-40 insulin, which may help avoid misdosing with other insulin syringes
- ½ unit scale marks designed to reduce the risk of over- or under-dosing
BD Microtainer® contact-activated lancet
The BD Microtainer® contact-activated lancet is ergonomically designed for a comfortable grip, providing greater confidence while handling the product. The design minimizes slippage that may occur during product activation, and it is easier to hold during the puncture.
- Activates only when it is positioned and pressed against the skin
- Facilitates a consistent puncture depth for easier sampling
- Minimizes the possibility of device activation when not in contact with the skin
- Retracts automatically into the device, which prevents the lancet from being reused
- Prevalence of diabetes in dogs (1 in 100); Nelson RE, Canine diabetes mellitus. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine 7th ed. St. Louis, MO: Saunders; 2010: 1782–1816.
- Dvm360.com, Diabetes mellitus in cats: Risk factors and treatment, P. Jane Armstrong, Apr 01, 2009.